Information Provided By:
Fly News Breaks for February 18, 2020
Feb 18, 2020 | 07:44 EDT
Barclays analyst Duffy Fischer believes Chemours' 2020 outlook underscores the company's attractive value opportunity. As volumes recover the company will likely capture a disproportionate share and at a higher price point than competitors, Fischer tells investors in a research note. He sees Chemours' 2020 EBITDA improving and raised his price target for the shares to $27 from $26 while keeping an Overweight rating on the shares.
News For CC From the Last 2 Days
There are no results for your query CC